Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3910639 | 0.94 | PTPN1 (0.53) | PTPN1PTPN2 | |
| SCHEMBL3908288 | 0.93 | PTPN1 (0.51) | PTPN1PTPN2 | |
| SCHEMBL3909588 | 0.92 | PTPN1 (0.61) | PTPN1PTPN2 | |
| SCHEMBL3907746 | 0.89 | PTPN1 (0.50) | PTPN1PTPN2 | |
| SCHEMBL3909743 | 0.88 | PTPN1 (0.53) | PTPN1PTPN2 | |
| SCHEMBL3905214 | 0.88 | PTPN1 (0.53) | PTPN1PTPN2 | |
| SCHEMBL3906773 | 0.87 | PTPN1 (0.51) | PTPN1PTPN2 | |
| SCHEMBL3906887 | 0.87 | PTPN1 (0.53) | PTPN1PTPN2 | |
| SCHEMBL3907568 | 0.87 | PTPN1 (0.51) | PTPN1PTPN2 | |
| SCHEMBL3907908 | 0.86 | PTPN1 (0.65) | PTPN1PTPN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7521473-B2 | Inhibitors of protein tyrosine phosphatase 1B | WYETH (US) | 2009-04-21 | — | — | US | disclosed |
| US-20050203087-A1 | Inhibitors of protein tyrosine phosphatase 1B | WYETH | 2005-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050203087-A1 | Inhibitors of protein tyrosine phosphatase 1B | PTPRO, PTPRS, PTPRM | PTPN1 11/4885PTPN2 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.